The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Varicella‐Zoster Virus–Specific Immune Responses to Herpes Zoster in Elderly Participants in a Trial of a Clinically Effective Zoster Vaccine
Open accessAbstract
BACKGROUND: The objectives of this study were to evaluate the association between varicella-zoster virus (VZV)-specific humoral and cell-mediated immunity (CMI) to herpes zoster (HZ) and protection against HZ morbidity and to compare immune responses to HZ and zoster vaccine. METHODS: In 981 elderly persons who developed HZ during a zoster vaccine efficacy trial (321 vaccinees and 660 placebo recipients) and 1362 without HZ (682 vaccinees and 680 placebo recipients), CMI was measured by VZV responder cell frequency and interferon-gamma enzyme-linked immunospot, and antibodies were measured by VZV enzyme-linked immunosorbent assay against affinity-purified VZV glycoproteins (gpELISA). RESULTS: Robust VZV CMI at HZ onset correlated with reduced HZ morbidity, whereas VZV gpELISA titers did not. Three weeks after HZ onset, gpELISA titers were highest in those with more severe HZ and were slightly increased in placebo recipients (compared with zoster vaccine recipients) and in older individuals. VZV CMI responses to HZ were similar in zoster vaccine and placebo recipients and were not affected by demographic characteristics or antiviral therapy, except for responder cell frequency at HZ onset, which decreased with age. When responses to zoster vaccine and HZ could be compared, VZV CMI values were similar, but antibody titers were lower. CONCLUSIONS: Higher VZV CMI at HZ onset was associated with reduced HZ severity and less postherpetic neuralgia. Higher antibody titers were associated with increased HZ severity and occurrence of postherpetic neuralgia. HZ and zoster vaccine generated comparable VZV CMI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults
Oxman, M. N., Levin, M. J., Johnson, G. R., Schmader, K. E., Straus, S. E., Gelb, L. D., Arbeit, R. D., Simberkoff, M. S., Gershon, A. A., Davis, L. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051016 · Cited by 2,412
Self-citationDevelopment of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases
Daut, R. L., Cleeland, C. S., & Flanery, R. C. (1983) · Pain · doi:10.1016/0304-3959(83)90143-4 · Cited by 1,562
The Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis
Hope-Simpson, R. E. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800106 · Cited by 1,386
Gnann, J. W., & Whitley, R. J. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp013211 · Cited by 781
The Incidence of Herpes Zoster
Donahue, J. G. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.15.1605 · Cited by 652
Postherpetic Neuralgia — Pathogenesis, Treatment, and Prevention
Kost, R. G., & Straus, S. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350107 · Cited by 641
Self-citationPain and its persistence in herpes zoster
Dworkin, R. H., & Portenoy, R. K. (1996) · Pain · doi:10.1016/0304-3959(96)03122-3 · Cited by 396
Varicella‐Zoster Virus–Specific Immune Responses in Elderly Recipients of a Herpes Zoster Vaccine
Levin, M. J., Oxman, M. N., Zhang, J. H., Johnson, G. R., Stanley, H., Hayward, A. R., Caulfield, M. J., Irwin, M. R., Smith, J. G., Clair, J., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/528696 · Cited by 355
Self-citationYoshikawa, T. T., & Schmader, K. (2001) · Clinical Infectious Diseases · doi:10.1086/320169 · Cited by 335
Self-citationLevin, M. J., Smith, J. G., Kaufhold, R. M., Barber, D., Hayward, A. R., Chan, C. Y., Chan, I. S. F., Li, D. J. J., Wang, W., Keller, P. M., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/379048 · Cited by 314
Self-citationHerpes Zoster and Human Immunodeficiency Virus Infection
Buchbinder, S. P., Katz, M. H., Hessol, N. A., Liu, J. Y., O'Malley, P. M., Underwood, R., & Holmberg, S. D. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/166.5.1153 · Cited by 309
Coplan, P. M., Schmader, K., Nikas, A., Chan, I. S. F., Choo, P., Levin, M. J., Johnson, G., Bauer, M., Williams, H. M., Kaplan, K. M., et al. (2004) · The Journal of Pain · doi:10.1016/j.jpain.2004.06.001 · Cited by 306
Self-citationUse of an Inactivated Varicella Vaccine in Recipients of Hematopoietic-Cell Transplants
Hata, A., Asanuma, H., Rinki, M., Sharp, M., Wong, R. M., Blume, K., & Arvin, A. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013441 · Cited by 300
Immune Responses to Varicella-Zoster in the Aged
Burke, B. L. (1982) · Archives of Internal Medicine · doi:10.1001/archinte.1982.00340150091017 · Cited by 295
Selective decline in cellular immune response to varicella‐zoster in the elderly
Miller, A. E. (1980) · Neurology · doi:10.1212/wnl.30.6.582 · Cited by 277
Antigen persistence is required throughout the expansion phase of a CD4+ T cell response
Obst, R., van Santen, H.-M., Mathis, D., & Benoist, C. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042521 · Cited by 269
Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged
Berger, R., Florent, G., & Just, M. (1981) · Infection and Immunity · doi:10.1128/iai.32.1.24-27.1981 · Cited by 218
Smith, J. G., Liu, X., Kaufhold, R. M., Clair, J., & Caulfield, M. J. (2001) · Clinical Diagnostic Laboratory Immunology · doi:10.1128/cdli.8.5.871-879.2001 · Cited by 179
Self-citationHope-Simpson, R. E. (1975) · PubMed · Cited by 172
Levin, M. J., Barber, D., Goldblatt, E., Jones, M., LaFleur, B., Chan, C. Y., Stinson, D., Zerbe, G. O., & Hayward, A. R. (1998) · The Journal of Infectious Diseases · doi:10.1086/514264 · Cited by 148
Self-citationLi, S., CHAN, A. S. F., Matthews, H., Heyse, J. F., Chan, C. Y., Kuter, B. J., Kaplan, K. M., VESSEY, S. J. R., & SADOFF, J. C. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200204000-00014 · Cited by 126
Weinberg, A., Betensky, R. A., Zhang, L., & Ray, G. (1998) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.5.6.804-807.1998 · Cited by 83
Self-citationBerman, J. N., Wang, M., Berry, W. S., et al. (2005) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705191 · Cited by 53
Smith, J. G., Levin, M. J., Vessey, R., Chan, I. S. F., Hayward, A. R., Liu, X., Kaufhold, R. M., Clair, J. S., Chalikonda, I., Chan, C. Y., et al. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10318 · Cited by 52
Self-citationHammond, O., Wang, Y., Green, T., Antonello, J. M., Kuhn, R., Motley, C., Stump, P., Rich, B., Chirmule, N. B., & Marchese, R. D. (2006) · Journal of Medical Virology · doi:10.1002/jmv.20754 · Cited by 48
Self-citationImmune responses to varicella-zoster in the aged
Burke, B. L. (1982) · Archives of Internal Medicine · doi:10.1001/archinte.142.2.291 · Cited by 46
Patterson‐Bartlett, J., Levin, M. J., Lang, N., Schödel, F. P., Vessey, R., & Weinberg, A. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.07.051 · Cited by 45
Self-citationClinical application of responder cell frequency estimates with four years of follow up
Hayward, A. R., Zerbe, G. O., & Levin, M. J. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90242-9 · Cited by 44
Self-citation
Cited by
Correlates of protection induced by vaccination
Plotkin, S. A. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00131-10 · Cited by 1,745
Cohen, J. I. (2013) · New England Journal of Medicine · doi:10.1056/nejmcp1302674 · Cited by 734
Molecular mechanisms of varicella zoster virus pathogenesis
Zerboni, L., Sen, N., Oliver, S. L., & Arvin, A. M. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3215 · Cited by 477
Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50-59 Years
Schmader, K. E., Levin, M. J., Gnann, J. W., McNeil, S. A., Vesikari, T., Betts, R. F., Keay, S., Stek, J. E., Bundick, N. D., Su, S.-C., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir970 · Cited by 430
Self-citationNomenclature for Immune Correlates of Protection After Vaccination
Plotkin, S. A., & Gilbert, P. B. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis238 · Cited by 347
Metadata
- Authors
- Weinberg, A., Zhang, J. H., Oxman, M. N., Johnson, G. R., Hayward, A. R., Caulfield, M. J., Irwin, M. R., Clair, J., Smith, J. G., Stanley, H., Marchese, R. D., Harbecke, R., Williams, H. M., Chan, I. S. F., Arbeit, R. D., Gershon, A. A., Schödel, F., Morrison, V. A., Kauffman, C. A., Straus, S. E., Schmader, K. E., Davis, L. E., Levin, M. J., & the US Department of Veterans Affairs (VA) Cooperative Studies Program Shingles Prevention Study Investigators
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-10
- Volume
- 200
- Issue
- 7
- Pages
- 1068-1077
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2165687705
- Cited by
- 271
- References
- 28
- FWCI
- 11.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.